Skip to content

A Multicenter Randomized Open-Label Study evaluating AI-powered applications for dietary intake in gastric cancer patients who receive curative treatment

A Multicenter Randomized Open-Label Study evaluating AI-powered applications for dietary intake in gastric cancer patients who receive curative treatment - A Multicenter Randomized Open-Label Study evaluating AI-powered applications for dietary intake in gastric cancer patients who receive curative treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057408
Enrollment
76
Registered
2025-03-26
Start date
2025-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

AI-powered applications support no AI-powered applications support

Sponsors

Yokohama City University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. age 18 years and over 2. patients who have undergone radical resection for gastric cancer 3. patients who can cook at home and take food orally after being discharged from hospital. 4. the patient must be able to access the internet environment and own a device that can use this website. 5. the patient's written consent to participate in the study has been obtained.

Exclusion criteria

Exclusion criteria: 1.Patient who do not have access to the Internet environment or do not have a device capable of using the Site. 2.Patients who are unable to use the Site due to cognitive or physical impairment or disability. 3.Patients who do not have access to a cooking environment at home or who are unable to take food orally. 4.Patients who are already using ReTabell at the time of registration or have withdrawn their consent to the Terms of Use and Agreement. 5.Patients deemed inappropriate for inclusion in the study by the principal investigator or co-principal investigator.

Design outcomes

Primary

MeasureTime frame
The primary endpoint was changes QOL score using Short Form-36 Health Survey (SF-36) during 4 weeks after registration.

Secondary

MeasureTime frame
The secondary endpoints were changes of oral dietary intake, body composition changes, and laboratory data during 4 weeks after registration.

Countries

Japan

Contacts

Public ContactHashimoto Itaru

Yokohama City University Department of Surgery

itarum1n1@hotmail.com0457972800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026